Nalaganje...
Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab, a real-life study
INTRODUCTION: Omalizumab, a monoclonal anti-immunoglobulin E antibody, has been successfully used as a supplementary therapy to improve asthma control in children aged ≥ 6 years with severe persistent allergic asthma. AIM: To demonstrate the quality of life in children with severe asthma and their c...
Shranjeno v:
| izdano v: | Postepy Dermatol Alergol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Termedia Publishing House
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5831278/ https://ncbi.nlm.nih.gov/pubmed/29507558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2017.71109 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|